Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in a rat model of anterior ischemic optic neuropathy (rAION)

Experimental Eye Research

Volumn 118, Issue , 2014, Pages 109-116

  Chang, Chung Hsing ^a   Huang, Tzu Lun ^b,c   Huang, Shun Ping ^b,c   Tsai, Rong Kung ^b,c,d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Granulocyte colony stimulating factor; Neuroprotection; RAION; Rat anterior ischemic optic neuropathy; Retinal ganglion cells

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ROSE BENGAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR ISCHEMIC OPTIC NEUROPATHY; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DRUG EFFECT; EVOKED VISUAL RESPONSE; LASER; MACROPHAGE; MALE; MICROGLIA; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OPTIC NERVE; PHOTOACTIVATION; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; VISION;

EID: 84890190228     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.11.012     Document Type: Article

References (41)

1. Arnold A.C. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. JNeuroophthalmol. 2003, 23:157-163.
2. Bernstein S.L., Guo Y., Kelman S.E., Flower R.W., Johnson M.A. Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest. Ophthalmol. Vis. Sci. 2003, 44:4153-4162.
3. Bernstein S.L., Johnson M.A., Miller N.R. Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models. Prog. Retin. Eye Res. 2011, 30:167-187.
4. Bu P., Basith B., Stubbs E.B., Perlman J.I. Granulocyte colony-stimulating factor facilitates recovery of retinal function following retinal ischemic injury. Exp. Eye Res. 2010, 91:104-106.
5. Demetri G.D., Griffin J.D. Granulocyte colony-stimulating factor and its receptor. Blood 1991, 78:2791-2808.
6. Dong F., Larner A.C. Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF); evidence of the role of a tyrosine kinase activity distinct from the janus kinases. Blood 2000, 95:656-1662.
7. Frank T., Schlachetzki J.C., Göricke B., Meuer K., Rohde G., Dietz G.P., Bähr M., Schneider A., Weishaupt J.H. Both systemic and local application of granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy. BMC Neurosci. 2009, 10:49-58.
8. Gibson C.L., Jones N.C., Prior M.J., Bath P.M., Murphy S.P. G-CSF suppresses edema formation and reduces interleukin1beta expression after cerebral ischemia in mice. J.Neuropathol. Exp. Neurol. 2005, 64:763-767.
9. Goldenberg-Cohen N., Guo Y., Margolis F.L., Miller N.R., Cohen Y., Bernstein S.L. Oligodendrocyte dysfunction following induction of experimental anterior optic nerve ischemia. Invest. Ophthalmol. Vis. Sci. 2005, 46:2716-2725.
10. Görgen I., Hartung T., Leist M., Niehörster M., Tiegs G., Uhlig S., Weitzel F., Wendel A. Granulocyte colony-stimulating factor treatment protectsrodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J.Immunol. 1992, 149:918-924.
11. Hasselblatt M., Jeibmann A., Riesmeier B., Maintz D., Schäbitz W.R. Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol. 2007, 113:45-51.
12. Hayreh S.S. Acute ischemic disorders of the optic nerve: pathogenesis, clinical manifestations and management. Ophthalmol. Clin. North Am. 1996, 9:407-442.
13. Hayreh S.S., Zimmerman M.B. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch. Clin. Exp. Ophthalmol. 2008, 246:1029-1046.
14. Hayreh S.S. Ischemic optic neuropathy. Prog. Retin Eye Res. 2009, 28:34-62.
15. Hayreh S.S. Management of ischemic optic neuropathies. Indian J. Ophthalmol. 2011, 59:123-136.
16. Hattenhauer M.G., Leavitt J.A., Hodge D.O., Grill R., Gray D.T. Incidence of nonarteritic anterior ischemic optic neuropathy. Am. J. Ophthalmol. 1997, 123:103-107.
17. Huang T.L., Chang C.H., Lin K.H., Sheu M.M., Tsai R.K. Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats. Exp. Eye Res. 2011, 92:112-119.
18. Janáky M., Fülöp Z., Pálffy A., Benedek K., Benedek G. Electrophysiological findings in patients with nonarteritic anterior ischemic optic neuropathy. Clin. Neurophysiol. 2006, 117:1158-1166.
19. Johnson L.N., Arnold A.C. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J.Neuroophthalmol. 1994, 14:38-44.
20. Kerr N.M., Chew S.S., Danesh-Meyer H.V. Non-arteritic anterior ischaemic optic neuropathy: a review and update. J.Clin. Neurosci. 2009, 16:994-1000.
21. Knox D.L., Kerrison J.B., Green W.R. Histopathologic studies of ischemic optic neuropathy. Trans. Am. Ophthalmol. Soc. 2000, 98:203-220.
22. Koda M., Nishio T., Kamada T., Someya Y., Okawa A., Mori C., Yoshinaga K., Okada S., Moriya H., Yamazaki M. Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res. 2007, 1149:223-231.
23. Kojima H., Otani A., Oishi A., Makiyama Y., Nakagawa S., Yoshimura N. Granulocyte colony-stimulating factor attenuates oxidative stress-induced apoptosis in vascular endothelial cells and exhibits functional and morphological protective effect in oxygen-induced retinopathy. Blood 2011, 117:1091-1100.
24. Levin L.A., Louhab A. Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy. Arch. Ophthalmol. 1996, 114:488-491.
25. Milligan C.E., Cunningham T.J., Levitt P. Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain. J.Comp. Neurol. 1991, 314:125-135.
26. Miser J., Storb R., Hansen J.A., Bensinger W. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993, 82:1981-1984.
27. Oishi A., Otani A., Sasabara M., Kojima H., Nakamura H., Yodoi Y., Yoshimura N. Granulocyte colony-stimulating factor protects retinal photoreceptor cells against light-induced damage. Invest. Ophthalmol. Vis. Sci. 2008, 49:5629-5635.
28. Rebolleda G., Perez-Lopez M., Casas-Llera P., Contreras I., Munoz-Negrete F.J. Visual and anatomical outcomes of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids. Graefes Arch. Clin. Exp. Ophthalmol. 2013, 251:255-260.
29. Salgado C., Vilson F., Miller N.R., Bernstein S.L. Cellular inflammation in nonarteritic anterior ischemic optic neuropathy and its primate model. Arch. Ophthalmol. 2011, 129:1583-1591.
30. Schneider A., Kruger C., Steigleder T., Weber D., Pitzer C., Laage R., Aronowski J., Maurer M.H., Gassler N., Mier W., Hasselblatt M., Kollmar R., Schwab S., Sommer C., Bach A., Kuhn H.G., Schäbitz W. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J.Clin. Invest. 2005, 115:2083-2098.
31. Shima C., Adachi Y., Minamino K., Okigaki M., Shi M., Imai Y., Yanai S., Takahashi K., Ikehara S. Neuroprotective effects of granulocyte colony-stimulating factor on ischemia-reperfusion injury of the retina. Ophthal. Res. 2012, 48:199-207.
32. Shyu W.C., Lin S.Z., Yang H.I., Tzeng Y.S., Pang C.Y., Yen P.S., Li H. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor stimulated stem cells. Circulation 2004, 110:1847-1854.
33. Slater B.J., Mehrabian Z., Guo Y., Hunter A., Bernstein S.L. Rodent anterior ischemic optic neuropathy (rAION) induces regional retinal ganglion cell apoptosis with a unique temporal pattern. Invest. Ophthalmol. Vis. Sci. 2008, 49:3671-3676.
34. Stoll G., Trapp B.D., Griffin J.W. Macrophage function during Wallerian degeneration of rat optic nerve: clearance of degenerating myelin and la expression. J.Neurosci. 1989, 9:2327-2335.
35. Tesser R.A., Niendorf E.R., Levin L.A. The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy. Ophthalmol 2003, 110:2031-2035.
36. Tsai K.J., Tsai Y.C., Shen C.K. G-CSF rescues the memory impairment of animal models of Alzheimer's disease. J.Exp. Med. 2007, 204:1273-1280.
37. Tsai R.K., Chang C.H., Wang H.Z. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats. Exp. Eye Res. 2008, 87:242-250.
38. Tsai R.K., Chang C.H., Sheu M.M., Huang Z.L. Anti-apoptotic effects of human granulocyte colony-stimulating factor (G-CSF) on retinal ganglion cells after optic nerve crush are PI3K/AKT-dependent. Exp. Eye Res. 2010, 90:537-545.
39. Weaver C.H., Buckner C.D., Longin K., Appelbaum F.R., Rowley S., Lilleby K., Miser J., Storb R., Hansen J.A., Bensinger W. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993, 82:1981-1984.
40. Wildberger H. Pattern-evoked potentials and visual field defects in ischaemic optic neuropathy. Doc. Ophthalmol. 1984, 40:193-201.
41. Wilson W.B. Visual-evoked response differentiation of ischemic optic neuritis from the optic neuritis of multiple sclerosis. Am. J. Ophthalmol. 1978, 86:530-535.